{
  "docId": "019de076-9336-7344-93bc-154185328b25",
  "docSlug": "edea36d6b00ed662cafb2da1a03c41ae",
  "documentTitle": "BenevolentAI | Investor Conference Presentation Deck | 22 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 18,
  "pageCount": 22,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "other",
  "function": "establish_context",
  "density": "overcrowded",
  "nDataPoints": 14,
  "notes": "The slide uses a process-like visual to represent the three parts of the study.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de076-9336-7344-93bc-154185328b25/18",
  "deckHref": "/decks/019de076-9336-7344-93bc-154185328b25",
  "deckJsonHref": "/decks/019de076-9336-7344-93bc-154185328b25.json",
  "deckAnchorHref": "/decks/019de076-9336-7344-93bc-154185328b25#slide-18",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.3,
        "x": 0.05,
        "y": 0.45
      },
      "kind": "list",
      "text": "Part A - SAD: 4 of upto 6 groups of healthy volunteers dosed @ 2mg, 6mg, 20mg and 60mg; 8 subjects per group: (6:2); Single oral doses of BEN-8744 administered in fasted state; Monitored up to 72h after dosing, with follow up 7 days after inpatient stay",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "548f31db-75fb-46b8-be42-850b9f7d96f0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.3,
        "x": 0.65,
        "y": 0.45
      },
      "kind": "list",
      "text": "Part C - MAD: First of upto 3 groups of healthy volunteers dosed; 8 subjects per group: (6:2); Daily (BID) oral doses of BEN-8744 for 14 days; Monitored up to 72h after dosing, with follow up 7 days after inpatient stay",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "896596fa-b1f5-4bf5-9cdb-3bb7e375be9d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.3,
        "x": 0.35,
        "y": 0.45
      },
      "kind": "list",
      "text": "Part B - Food Effect: Upto 2 groups of healthy volunteers; Scheduled 11th Dec; 6 subjects per group: 6 active; Crossover design with 2 sessions per subject, 7 days apart: One dose BEN-8744 fasted, One dose BEN-8744 after high fat meal",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bcc9f5d4-56be-4ef1-b794-842028b04c72",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.64,
        "x": 0.18,
        "y": 0.88
      },
      "kind": "paragraph",
      "text": "Study initiated in August 2023, topline data expected Q1 2024",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "761f6d4d-d89e-4a46-8fa2-393fcbc0588f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.26
      },
      "kind": "paragraph",
      "text": "Study conducted with healthy adult volunteers (18-65 y/o) at a phase 1 unit (HMR) in London, UK",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "82c91f32-42c4-4077-86c7-28335c4bf746",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "subtitle",
      "text": "Study objectives: To assess the safety and tolerability of single and multiple oral doses, and the effect of food on pharmacokinetic profile, of BEN-8744 in healthy volunteer subjects",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "956e8476-40cc-42d1-824b-0f2e7887c176",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.5,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "BEN-8744 Phase 1a study overview",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d381c6d1-0b5d-43e2-b141-55c41c073f83",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "b9631c76-8b44-4221-8d67-356da33e0560",
      "evidence": "The slide contains list/bullet points with detailed information about the study.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}